Wavelength Pharmaceuticals names Seri CEO

Wavelength Pharmaceuticals Ltd said Nov. 29 that Iftach Seri was named CEO, while Tami Cohen was appointed CFO. Seri previously served as Sun Pharmaceutical’s head of API. Cohen was formerly CFO of SodaStream’s manufacturing subsidiary and corporate controller. Wavelength is a portfolio company of SK Capital Partners.

29 November 2017•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles